Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-001509
Filing Date
2013-02-14
Accepted
2013-02-14 08:57:03
Documents
16
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q omni_10q-123112.htm 10-Q 582400
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 50461
3 EXHIBIT 10.2 ex10-2.htm EX-10.2 96261
4 EXHIBIT 10.3 ex10-3.htm EX-10.3 107256
5 EXHIBIT 10.4 ex10-4.htm EX-10.4 106032
6 EXHIBIT 10.5 ex10-5.htm EX-10.5 73950
7 EXHIBIT 10.6 ex10-6.htm EX-10.6 118808
8 EXHIBIT 31.1 ex31-1.htm EX-31.1 9363
9 EXHIBIT 31.2 ex31-2.htm EX-31.2 9264
10 EXHIBIT 32.1 ex32-1.htm EX-32.1 5786
  Complete submission text file 0001437749-13-001509.txt   3961399

Data Files

Seq Description Document Type Size
11 ombp-20121231.xml EX-101.INS 371915
12 ombp-20121231.xsd EX-101.SCH 38406
13 ombp-20121231_cal.xml EX-101.CAL 12032
14 ombp-20121231_def.xml EX-101.DEF 217827
15 ombp-20121231_lab.xml EX-101.LAB 311331
16 ombp-20121231_pre.xml EX-101.PRE 217645
Mailing Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111
Business Address 5350 SOUTH ROSLYN SUITE 400 GREENWOOD VILLAGE CO 80111 (303) 867-3415
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-52530 | Film No.: 13606527
SIC: 2836 Biological Products, (No Diagnostic Substances)